I am the assigned Gen-ART reviewer for this draft. For background on
Gen-ART, please see the FAQ at
<http://wiki.tools.ietf.org/area/gen/trac/wiki/GenArtfaq>.
Please resolve these comments along with any other Last Call comments
you may receive.
Document: draft-ietf-idr-rfd-usable-02
Reviewer: Vijay K. Gurbani
Review Date: Sep-6-2013
IETF LC End Date: Unknown
IESG Telechat date: Unknown
This draft is basically ready for publication, but has one minor issue
that should be fixed (or at least looked at) before publication.
Major: 0
Minor: 1
Nits: 0
Minor issue:
- This is a document on the standards track. Therefore, it is rather
disconcerting to see the following statement in the draft (end of
Section 2): "[This document] is not a panacea, nor is it a deep and
thorough approach to flap reduction."
I understand the panacea part, it is the trailing phrase that I want
to draw attention to.
Now, I am not a routing expert so I would presume that despite the
exhortations above, the chairs of the WG and the AD have looked at
the document and are comfortable with the sentence I have pointed out.
(Sorry if it has been discussed in the WG.) Assuming that is the
case, I am happy to proceed with this document. Assuming it is not,
would an Experimental designation be appropriate?
Thanks,
- vijay
--
Vijay K. Gurbani, Bell Laboratories, Alcatel-Lucent
1960 Lucent Lane, Rm. 9C-533, Naperville, Illinois 60563 (USA)
Email: vkg@{bell-labs.com,acm.org} / [email protected]
Web: http://ect.bell-labs.com/who/vkg/ | Calendar: http://goo.gl/x3Ogq
_______________________________________________
Gen-art mailing list
[email protected]
https://www.ietf.org/mailman/listinfo/gen-art
